In den Warenkorb
Bestellen Sie auch über:
![]() |
+33 (0)1 76 63 32 65 |
![]() |
+33 (0)1 74 18 08 22 |
MGMT (AA 8-221) Antikörper
| Antigen | MGMT |
| Epitope |
AA 8-221 |
| Klonalität | Monoklonal (MT3-1) |
| Wirt |
Maus |
| Reaktivität |
Human |
| Applikation |
Durchflusszytometrie (FACS), Immunhistochemie (Paraffinschnitte) (IHC (p)), Western Blot (WB)
|
![]() |
3 Publikationen vorhanden |
| Produktnummer | ABIN187469 |
| Menge | 0.1 mg |
| Preis | 523,08 € Zzgl. Versandkosten €40,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 7 bis 10 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | MGMT (8-221) |
| Immunogen | Purified recombinant human MGMT protein. |
| Isotyp | IgG1 (Passende Sekundärantikörper) |
| Klon | MT3-1 |
| Beschreibung | Cancer chemotherapeutic alkylating agents (e.g. BCNU) act by inducing formation of lethal cross-links at the O6-alkylguanine position in DNA. MGMT (O6-methylguanine-DNA methyltransfer-ase) transfers alkyl adducts from the O6-position of guanine in DNA (prior to cross-link formation) to a cysteine residue in its own sequence, thereby restoring DNA to its intact state. This transfer inactivates the MGMT enzyme and is irreversible, hence the level of MGMT in a cell is directly proportional to the level of DNA-damage it can tolerate. In normal tissues, MGMT acts as a suppressor of mutation and carcinogenesis. Tumors with high levels of MGMT are likely to be drug-resistant. |
| Spezifität | Species Reactivity: Human. Cross-reacts weakly with mouse, rat and hamster. Other species not tested. Molecular Weight: .25 kDa Cellular Location: Nuclear and cytoplasmic.Positive Control: Raji cells, Colon carcinoma. |
Anwendungen
| Applikationshinweise | Flow cytometry Immunohistochemistry: (formalin / paraffin) Use at a 1:20 - 1:40 dilution for 60 minutes at room temperature (RT). Staining of formalin-fixed tissues REQUIRES boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10 - 20 minutes followed by cooling at RT for 20 minutes. Note: IHC requires the use of a high-efficiency detection system. Western blot: Use at 0.5-1 µg/mL for 2 hours at RT. The optimal dilution for a specific application should be determined by the researcher. |
| Buffer | 500 µL of monoclonal antibody at 200 µg/mL in 10 mM PBS, pH 7.4, with protein stabilizer and 0.09% sodium azide. Purified from ascites fluid by Protein G chromatography. |
| Lagerung | Store at 4 °C. |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Publikationen
| Publikationen |
Reese, Roth, Gerson: "Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance." in: Stem cells (Dayton, Ohio), Vol. 26, Issue 3, pp. 675-81, 2008 (PubMed).
Rietschel, Wolchok, Krown et al.: "Phase II study of extended-dose temozolomide in patients with melanoma." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, Issue 14, pp. 2299-304, 2008 (PubMed). Cui, Johnson, Bullock et al.: "Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway." in: Molecular pharmacology, Vol. 75, Issue 6, pp. 1356-63, 2009 (PubMed). |




